GSK4172239D
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK4172239D, covering 2026-01-22 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years [Phase 1]